+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Operating RegenMed: development of better in-theater strategies for handling tissue-engineered organs and tissues

Operating RegenMed: development of better in-theater strategies for handling tissue-engineered organs and tissues

Regenerative Medicine 9(6): 785-791

Tissue engineering ex vivo and direct cellular application with bioscaffolds in vivo has allowed surgeons to restore and establish function throughout the human body. The evidence for regenerative surgery is growing, and consequently there is a need for the development of more advanced regenerative surgery facilities. Regenerative medicine in the surgical field is changing rapidly and this must be reflected in the design of any future operating suite. The theater environment needs to be highly adaptable to account for future significant advances within the field. Development of purpose built, combined operating suites and tissue-engineering laboratories will provide the facility for modern surgeons to treat patients with organ deficits, using bespoke, regenerated constructs without the need for immunosuppression.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 058462532

Download citation: RISBibTeXText

PMID: 25431914

DOI: 10.2217/rme.14.46

Related references

Role of nanotopography in the development of tissue engineered 3D organs and tissues using mesenchymal stem cells. World Journal of Stem Cells 7(2): 266-280, 2015

Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development. Cell Stem Cell 22(3): 310-324, 2018

Shutting down operating theater ventilation when the theater is not in use: infection control and environmental aspects. Infection Control and Hospital Epidemiology 24(8): 596-600, 2003

Theater overshoes do not reduce operating theater floor bacterial counts. Journal of Hospital Infection 17(2): 117-124, 1991

Are synthetic scaffolds suitable for the development of clinical tissue-engineered tubular organs?. Journal of Biomedical Materials Research. Part A 102(7): 2427-2447, 2015

The application of nanotopography in the development of tissue engineered tissues using mesenchymal stem cells. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 35(1): 145-150, 2018

A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs: from concept to clinical trial. Biomaterials 30(29): 5260-5269, 2009

Tissue engineered vascular grafts: Origins, development, and current strategies for clinical application. Methods 99: 13-19, 2015

Development concepts of a Smart Cyber Operating Theater (SCOT) using ORiN technology. Biomedizinische Technik. Biomedical Engineering, 2017

Theater as praxis: discursive strategies in African popular theater. African Studies Review 33(1): 65-92, 1990

An adipoinductive role of inflammation in adipose tissue engineering: key factors in the early development of engineered soft tissues. Stem Cells and Development 22(10): 1602-1613, 2014

Safe practice in the operating theater: accidents to patients in the operating room theatre. Nursing Times 74(44): Suppl 5-7, 1978

Engineered whole organs and complex tissues. Lancet 379(9819): 943-952, 2012

Effect of switching off unidirectional downflow systems of operating theaters during prolonged inactivity on the period before the operating theater can safely be used. American Journal of Infection Control (): -, 2016

Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues. Biomaterials 27(36): 6083-6095, 2006